New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
06:23 EDTMDT, COV, JNJMedtronic deal likely to get 'significant political attention,' says Citigroup
Citigroup believes Medtronic's (MDT) acquisition of Covidien (COV) is likely to get "significant political attention" as the largest agreed upon tax inversion deal. Citi, however, believes both companies have thoroughly vetted the risk. The firm thinks that with annual sales of $27B, the combined company is now "within striking distance" of Johnson & Johnson's (JNJ) MD&D division. Citi has a Buy rating on Medtronic with a $69 price target.
News For MDT;COV;JNJ From The Last 14 Days
Check below for free stories on MDT;COV;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 28, 2014
06:52 EDTMDT, COVFormer official says Obama could limit inversion deals, NY Times reports
President Obama could limit tax inversion deals on his own authority, said Stephen Shay, former deputy assistant Treasury secretary for international tax affairs in the Obama administration, according to The New York Times. A 1969 law gives the president the ability to restrict inversion deals, said Shay, who also worked in the Reagan administration, the newspaper stated. Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Alletgan (AGN). Reference Link
06:32 EDTJNJJ&J dispute with Boston Scientific looks set to go to trial, NY Times says
Subscribe for More Information
July 25, 2014
08:54 EDTJNJEMA issues positive opinion, recommends approval of Imbruvica
Subscribe for More Information
07:17 EDTJNJEMA recommends approval for Gilead, Janssen blood cancer drugs
Subscribe for More Information
06:30 EDTMDT, COVObama calls on Congress to end inversion deals, NY Times reports
Subscribe for More Information
06:05 EDTCOVCovidien reports Q3 Surgical Solutions sales up 8% to $1.31B
Reports Q3 Vascular Therapies sales flat to $417M; Reports Q3 Respiratory and Patient Care sales up 2% to $966M.
06:03 EDTCOVCovidien reports Q3 adjusted EPS $1.04, consensus $1.00
Subscribe for More Information
July 24, 2014
15:29 EDTCOVNotable companies reporting before tomorrow's open
Subscribe for More Information
14:35 EDTCOVObama to call for elimination of tax inversion deals, NY Times says
President Obama will call on Congress today to eliminate the tax inversion loophole, according to The New York Times. Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott’s (ABT), Medtronic's acquisition of Covidien (COV)and Valeant's (VRX) proposed takeover of Alletgan (AGN)Reference Link
09:16 EDTJNJOn The Fly: Pre-market Movers
Subscribe for More Information
08:39 EDTJNJOrganovo enters 3D bio-printed tissue agreement with J&J unit
Organovo (ONVO) announced that it has entered into an agreement with Janssen Research and Development, a pharmaceutical company of Johnson & Johnson (JNJ), to evaluate the use of 3D bio-printed tissue in a drug discovery setting, outside of the company’s work in 3D liver tissue for toxicity testing. Terms were not disclosed.
08:19 EDTJNJ, MDTLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
July 23, 2014
06:45 EDTCOVLawmakers divided on inversion deals, NY Times says
Subscribe for More Information
July 22, 2014
07:07 EDTCOVCovidien names Bryan Hanson as group president, effective October 1
Subscribe for More Information
July 21, 2014
18:40 EDTJNJOn The Fly: After Hours Movers
UP AFTER EARNINGS: Netflix (NFLX), up marginally after reporting Q2 results... Sanmina (SANM), up 13.2% after reporting third quarter results and fourth quarter guidance above analyst estimates... Chipotle (CMG), up 10.1%... Helix (HLX), up 5.2%... Canadian National (CNI), up 1.13%... CYS Investments (CYS), up 1.7%. ALSO HIGHER: Apache (APA), up 5% after Bloomberg says JANA discloses $1B position... Johnson & Johnson (JNJ), up 1% after announcing a $5B share repurchase program... TG Therapeutics (TGTX), up 4.3% after reporting second quarter results and preliminary clinical results from TG-1101 Phase I study... DOWN AFTER EARNINGS: Rambus (RMBS), down 3.6% after reporting second quarter results... Ultra Clean (UCTT), down 4% after reporting quarterly results. ALSO LOWER: Tallgrass Energy (TEP), down 5% after filing to sell 7M common units representing limited partners.
17:03 EDTJNJJohnson & Johnson announces $5B share repurchase program
Johnson & Johnson announced that its board has approved the repurchase of up to $5B of the company's common stock. The company had approximately 2.82B shares of common stock outstanding as of June 29.
17:01 EDTJNJJohnson & Johnson announces $5B share repurchase program
08:16 EDTCOV, MDTDeutsche Bank analysts hold an analyst/industry conference call
Subscribe for More Information
July 18, 2014
12:51 EDTMDT, COVKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
11:34 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use